These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3409547

  • 1. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice.
    Claverie N, Pasquali JL, Mamont PS, Danzin C, Weil-Bousson M, Siat M.
    Clin Exp Immunol; 1988 May; 72(2):293-8. PubMed ID: 3409547
    [Abstract] [Full Text] [Related]

  • 2. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.
    Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine an inhibitor of polyamine synthesis: I. Effects on mitogen-induced immunoglobulin production in human cultured lymphocytes.
    Pasquali JL, Mamont PS, Weryha A, Knapp AM, Blervaque A, Siat M.
    Clin Exp Immunol; 1988 Apr; 72(1):141-4. PubMed ID: 3396214
    [Abstract] [Full Text] [Related]

  • 4. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 5. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
    Bartholeyns J, Mamont P, Casara P.
    Cancer Res; 1984 Nov; 44(11):4972-7. PubMed ID: 6435861
    [Abstract] [Full Text] [Related]

  • 6. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
    Claverie N, Mamont PS.
    Cancer Res; 1989 Aug 15; 49(16):4466-71. PubMed ID: 2501026
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 8. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
    Zhai ZF, Zhou CL, Zhong BY, Ao JH, Hao F.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):406-10. PubMed ID: 18581896
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE.
    J Autoimmun; 1997 Aug 05; 10(4):367-73. PubMed ID: 9237800
    [Abstract] [Full Text] [Related]

  • 10. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 11. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL, Cohen P, Williams D, O'Brien K, Volkman A, Eisenberg R.
    J Immunol; 1993 Jan 15; 150(2):695-9. PubMed ID: 8419494
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 15; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 13. Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus.
    Halpern MD, Craven SY, Cohen PL, Eisenberg RA.
    J Immunol; 1993 Dec 15; 151(12):7268-72. PubMed ID: 8258724
    [Abstract] [Full Text] [Related]

  • 14. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
    Eisenberg RA, Craven SY, Cohen PL.
    J Immunol; 1987 Aug 01; 139(3):728-33. PubMed ID: 3474277
    [Abstract] [Full Text] [Related]

  • 15. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.
    Cytokine; 2000 Jul 01; 12(7):1035-41. PubMed ID: 10880249
    [Abstract] [Full Text] [Related]

  • 16. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J, Xu J, Madaio MP, Peng Q, Zhang J, Grewal IS, Flavell RA, Craft J.
    J Immunol; 1996 Jul 01; 157(1):417-26. PubMed ID: 8683147
    [Abstract] [Full Text] [Related]

  • 20. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C.
    J Pineal Res; 2008 Sep 01; 45(2):204-11. PubMed ID: 18507713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.